Genpact Total Stockholder Equity vs Non Current Liabilities Total Analysis
G Stock | USD 45.94 4.13 9.88% |
Genpact financial indicator trend analysis is much more than just examining Genpact Limited latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Genpact Limited is a good investment. Please check the relationship between Genpact Total Stockholder Equity and its Non Current Liabilities Total accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genpact Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
Total Stockholder Equity vs Non Current Liabilities Total
Total Stockholder Equity vs Non Current Liabilities Total Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Genpact Limited Total Stockholder Equity account and Non Current Liabilities Total. At this time, the significance of the direction appears to have strong relationship.
The correlation between Genpact's Total Stockholder Equity and Non Current Liabilities Total is 0.74. Overlapping area represents the amount of variation of Total Stockholder Equity that can explain the historical movement of Non Current Liabilities Total in the same time period over historical financial statements of Genpact Limited, assuming nothing else is changed. The correlation between historical values of Genpact's Total Stockholder Equity and Non Current Liabilities Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Stockholder Equity of Genpact Limited are associated (or correlated) with its Non Current Liabilities Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Liabilities Total has no effect on the direction of Total Stockholder Equity i.e., Genpact's Total Stockholder Equity and Non Current Liabilities Total go up and down completely randomly.
Correlation Coefficient | 0.74 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Non Current Liabilities Total
Most indicators from Genpact's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Genpact Limited current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genpact Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. The Genpact's current Sales General And Administrative To Revenue is estimated to increase to 0.26, while Selling General Administrative is projected to decrease to roughly 576 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 1.4B | 1.5B | 1.6B | 902.8M | Total Revenue | 4.0B | 4.4B | 4.5B | 2.4B |
Genpact fundamental ratios Correlations
Click cells to compare fundamentals
Genpact Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Genpact fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 4.5B | 4.9B | 5.0B | 4.6B | 4.8B | 3.1B | |
Total Stockholder Equity | 1.7B | 1.8B | 1.9B | 1.8B | 2.2B | 1.4B | |
Net Debt | 1.3B | 1.3B | 1.1B | 1.0B | 919.3M | 965.3M | |
Retained Earnings | 648.7M | 741.7M | 732.5M | 780.0M | 1.1B | 1.1B | |
Cash | 467.1M | 680.4M | 899.5M | 646.8M | 583.7M | 449.6M | |
Other Assets | 478.8M | 961.1M | 667.3M | 439.6M | 1.0 | 0.95 | |
Cash And Short Term Investments | 467.1M | 680.4M | 899.5M | 646.8M | 583.7M | 472.7M | |
Common Stock Shares Outstanding | 195.2M | 195.8M | 193.0M | 188.1M | 185.1M | 200.1M | |
Liabilities And Stockholders Equity | 4.5B | 4.9B | 5.0B | 4.6B | 4.8B | 3.1B | |
Other Stockholder Equity | 1.6B | 1.6B | 1.7B | 1.8B | 1.9B | 1.3B | |
Total Liab | 2.8B | 3.0B | 3.1B | 2.8B | 2.6B | 1.6B | |
Total Current Assets | 1.6B | 1.7B | 1.9B | 1.8B | 1.9B | 1.2B | |
Short Long Term Debt Total | 1.8B | 1.9B | 2.0B | 1.7B | 1.5B | 950.6M | |
Other Current Liab | 629.7M | 694.0M | 678.2M | 675.7M | 409.4M | 455.6M | |
Total Current Liabilities | 910.2M | 1.2B | 1.3B | 1.1B | 1.3B | 758.6M | |
Other Liab | 192.2M | 239.9M | 249.2M | 208.0M | 239.2M | 192.5M | |
Property Plant And Equipment Net | 584.9M | 535.8M | 485.7M | 379.1M | 393.7M | 285.6M | |
Current Deferred Revenue | 97.3M | 154.7M | 160.6M | 160.6M | 112.4M | 77.9M | |
Accounts Payable | 22.0M | 13.9M | 25.0M | 35.8M | 27.7M | 20.2M | |
Non Current Assets Total | 2.9B | 3.1B | 3.1B | 2.8B | 2.9B | 1.9B | |
Non Currrent Assets Other | 217.1M | 323.8M | 322.2M | 450.5M | 379.6M | 213.0M | |
Long Term Debt | 1.3B | 1.3B | 1.3B | 1.2B | 824.7M | 690.1M | |
Net Receivables | 914.3M | 881.0M | 887.7M | 994.8M | 1.1B | 613.1M | |
Good Will | 1.6B | 1.7B | 1.7B | 1.7B | 1.7B | 1.2B | |
Common Stock Total Equity | 1.9M | 1.9M | 1.8M | 1.8M | 1.6M | 2.6M | |
Non Current Liabilities Total | 1.9B | 1.8B | 1.8B | 1.7B | 1.2B | 966.8M | |
Inventory | 121.2M | 150.1M | 103.7M | 1.0 | (137.5M) | (130.6M) | |
Other Current Assets | 49.2M | 37.3M | 30.7M | 138.0M | 169.0M | 177.5M | |
Property Plant And Equipment Gross | 618.4M | 585.9M | 485.7M | 379.1M | 984.1M | 1.0B | |
Accumulated Other Comprehensive Income | (532.0M) | (545.3M) | (554.4M) | (733.1M) | (722.6M) | (686.4M) | |
Short Term Debt | 161.2M | 340.0M | 445.0M | 231.2M | 503.4M | 528.6M | |
Intangible Assets | 230.9M | 236.7M | 169.6M | 89.7M | 53.0M | 50.4M | |
Common Stock | 1.9M | 1.9M | 1.8M | 1.8M | 1.8M | 2.5M | |
Property Plant Equipment | 254.0M | 231.1M | 485.7M | 379.1M | 436.0M | 238.5M | |
Short Term Investments | 1.8M | 8.8M | 5.8M | 5.4M | 4.4M | 4.2M | |
Net Tangible Assets | (116.2M) | (98.2M) | (3.5M) | 52.2M | 47.0M | 44.7M |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genpact Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Data Processing & Outsourced Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genpact. If investors know Genpact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genpact listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.156 | Dividend Share 0.595 | Earnings Share 3.64 | Revenue Per Share 25.964 | Quarterly Revenue Growth 0.066 |
The market value of Genpact Limited is measured differently than its book value, which is the value of Genpact that is recorded on the company's balance sheet. Investors also form their own opinion of Genpact's value that differs from its market value or its book value, called intrinsic value, which is Genpact's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genpact's market value can be influenced by many factors that don't directly affect Genpact's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genpact's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genpact is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genpact's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.